The lack of response of the LND-1 cells to anti-PD1/PBMCs when the experiment was conducted in the presence of circulating EVs could depend on the absence of the tumor microenvironment which contributes to the immunotherapy response [30]. The gene discussed is PDCD1; the disease is neoplasm.